SAN JOSE – The owners of a large office complex in northern San Jose are now actively marketing the project to life science companies as the demand for space from biotech and related businesses soars.
North First assembly at a select San Jose location will be offered as a Silicon Valley campus for life science companies. This adds to its original mission as a modern tech campus.
The 27 hectare office and research complex is an extensive renovation and refurbishment that has so far created around 300,000 square meters of modern office space in three buildings.
Real estate agents Michael Rosendin, Craig Fordyce and Shane Minnis of Colliers International, a commercial real estate company, are looking for tenants to assemble in North First.
“From a market standpoint, we are promoting the project as suitable for life science companies,” said Minnis, vice president, Colliers International.
The developers ProspectHill Group, SKS Partners and Invesco Real Estate are leading the redevelopment of the campus, which could total more than 1.3 million square meters in north San Jose.
“Ideal for medical devices and life sciences,” says a marketing brochure for assembly at North First. The brochure also lists about 36 life science companies that operate near the complex, including titans like Varian, Johnson & Johnson, Roche, Abbott, and Boston Scientific. The brochure adds, “Be in good company.”
The complex is on the corner of North First Street and Headquarters Way and also has a facade on Rose Orchard Way. It is not far from a major intersection of the North First and Tasman Drive light rail lines.
“We market in both the technology and life sciences sectors,” said Fordyce, executive vice president, Colliers. “The life sciences are one of the few industries that are not affected by COVID and are indeed in greater demand because of the coronavirus.”